US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding ...

France-based SparingVision, a genomic medicine company focused on the treatment of retinal disease, has announced the appointment of Kalliopi ‘Kali’ Stasi, as chief medical officer, effective ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

The Russian pharmaceutical market, valued at around $41 billion, continues to be a magnet for Indian pharmaceutical companies ...